R&D
MDS
GMP & PIPELINE
PRODUCT
PUBLICATIONS
INVESTORS
DISCLOSURES
FINANCES
STOCK PRICE
INVESTORS RELATIONS
PEOPLEBIO
ENGLISH
KOREAN
ENGLISH
KOREAN
R&D
MDS
GMP & PIPELINE
PRODUCT
PUBLICATIONS
INVESTORS
DISCLOSURES
FINANCES
STOCK PRICE
INVESTORS RELATIONS
PEOPLEBIO
PUBLICATIONS
PeopleBio is continuously publishing peer-reviewed research.
PUBLICATIONS
2020
Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study
Youn YC, Lee BS, Kim GJ, Ryu JS, Lim K, Lee R, Suh J, Park YH, Pyun JM, Ryu N, Kang MJ, Kim HR, Kang S, An SSA, Kim SY
2020
Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer’s Disease in Health Screening Population
Lee JJ, Choi Y, Chung S, Yoon DH, Choi SH, Kang S, Seo D, Park K
2019
Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease
Xue Meng, Tao Li, Xiao Wang, Xiaozhen Lv, Zhiyu Sun, Zhang J, Feng Su, Kang S, Kim SY, An SSA, Xin Yu, Chen Zhang, Huali Wang
2019
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
Youn YC, Kang S, Suh J, Park YH, Kang MJ, Pyun J, Choi SH, Jeong JH, Park KW, Lee HW, An SSA, Jacqueline C Dominguez, Kim SY
2017
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
Wang MJ, Yi SH, Han J, Park SY, Jang J, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim SY
01
02
03